跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
RANOLAZINA OLPHA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
RANOLAZINA OLPHA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Olpha As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 27, 2022
Approval ID
0ccd08904253bb09
Company
Olpha As
Type
Standard
Approval Details
Approval Id
0ccd08904253bb09
Drug Cima Aemps Name
RANOLAZINA OLPHA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
88125
Holder Company Name
Olpha As
Marketing Company Name
Olpha As
Authorization Date
2022-12-27
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
500 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Olpha As
Active Ingredients
RANOLAZINA
500 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 27, 2022
Approval ID
0ccd08904253bb09
Type
Standard
Back to CIMA-AEMPS Approvals
RANOLAZINA OLPHA 500 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
